查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722407

2025 年至 2033 年一次性生物反应器市场报告（按产品类型、类型、细胞类型、分子类型、最终用户和地区）

Single-Use Bioreactors Market Report by Product Type, Type, Cell Type, Molecule Type, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球一次性生物反应器市场规模达 39 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 124 亿美元，2025-2033 年期间的成长率 (CAGR) 为 13.1%。市场受到生物製药需求不断增长、产品提供的成本效益和可扩展性、一次性技术的重大发展、合约製造组织 (CMO) 中产品采用率不断提高、细胞和基因治疗生产中使用率不断提高的推动。

一次性生物反应器市场分析：

主要市场驱动因素：生物製药需求的不断增长、产品提供的成本效益和可扩展性以及一次性技术的重大发展是一些主要的市场驱动因素。

主要市场趋势：合约製造组织 (CMO) 中产品采用率的不断增长、细胞和基因治疗生产中利用率的不断提高以及生物反应器设计的重大进步是一次性生物反应器的一些主要市场趋势。

地理趋势：由于生物製药的使用量不断增加、生物加工技术的投资不断增加以及一次​​性系统比传统钢製生物反应器的优势不断增强，北美占据了市场主导地位。

竞争格局：ABEC Inc.、Cellexus、Celltainer Biotech BV、CESCO Bioengineering Co. Ltd.、Distek Inc.、Eppendorf SE、通用电气公司、Getinge AB、Merck KGaA、Pall Corporation（丹纳赫公司）、PBS Biotech Inc.、Sartorius AG 和赛默世尔？

挑战与机会：该行业面临的一些挑战包括高初始产品成本和对塑胶废物日益增长的担忧。然而，市场机会包括单一生物反应器设计的重大技术发展以及个人化医疗和小批量生产日益增长的需求。

一次性生物反应器市场趋势：

生物製药的采用率不断上升

由于对多种疾病（包括糖尿病、癌症和自体免疫疾病等慢性疾病）的新型有效治疗方法的需求不断增加，生物製药产业正在快速成长。根据IMARC GROUP的数据，全球生物製药市场规模在2023年已达到3,005亿美元，预计到2032年将达到6,439亿美元，2024-2032年期间的复合年增长率为8.6%。疫苗、单株抗体、重组蛋白等生物製药都是利用活细胞生产的，需要高度专业的生产环境。一次性生物反应器 (SUB) 因其成本效益高、灵活性强且交叉污染风险低而被广泛采用。它们可以加快产品开发和生产时间，从而使生物製药公司能够快速满足这些需求并为患者开发新的治疗方法。

生物加工技术投资不断增加

随着生物加工技术寻求提高生产能力和营运效率，对生物加工技术的投资也不断增加。根据IMARC GROUP发布的报告，全球生物製程技术市场规模在2023年已达292亿美元，预计到2032年将达到533亿美元，2024-2032年期间的复合年增长率为6.93%。一次性生物反应器能够透过提供多种优势来组织生物加工工作流程，例如减少资本支出、最大限度地减少清洁和验证要求以及在扩大或缩小生产量方面具有更好的灵活性。主要参与者正在大力投资一次性技术，以最大限度地提高生产流程、最大限度地减少停机时间并实现成本效益。

有利的监管支持和政府政策

监管机构和政府机构透过制定持久的指导方针和框架来确保产品的安全性、有效性和质量，在改变生物製药製造格局方面发挥重要作用。近年来，监管界越来越认识到一次性生物反应器（SUB）的好处。美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等监管机构一直支持一次性技术，因为它们能够降低污染风险并提高流程效率。这种监管支持为 SUB 的采用提供了有利的环境，鼓励生物製药公司投资这些系统。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球一次性生物反应器市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 一次性生物反应器系统
  • 媒体包
  • 过滤组件
  • 其他的

第七章：市场区隔：依类型

  • 搅拌槽生物反应器
  • 波浪诱导生物反应器
  • 鼓泡塔生物反应器
  • 其他的

第八章：市场细分：按电池类型

  • 哺乳动物细胞
  • 细菌
  • 酵母菌
  • 其他的

第九章：市场细分：依分子类型

  • 疫苗
  • 单株抗体
  • 干细胞
  • 重组蛋白
  • 其他的

第十章：市场区隔：依最终用户

  • 製药和生物製药公司
  • 合约研究组织
  • 学术和研究机构
  • 其他的

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • ABEC Inc.
    • Cellexus
    • Celltainer Biotech BV
    • CESCO Bioengineering Co. Ltd.
    • Distek Inc.
    • Eppendorf SE
    • General Electric Company
    • Getinge AB
    • Merck KGaA
    • Pall Corporation (Danaher Corporation)
    • PBS Biotech Inc.
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A5151

The global single-use bioreactors market size reached USD 3.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.4 Billion by 2033, exhibiting a growth rate (CAGR) of 13.1% during 2025-2033. The market is propelled by the increasing demand for biopharmaceuticals, cost-efficiency and scalability offered by the product, significant developments in single-use technology, increasing product adoption in contract manufacturing organizations (CMOs), rising usage in cell and gene therapy production.

Single-Use Bioreactors Market Analysis:

Major Market Drivers: Increasing demand for biopharmaceuticals, cost-efficiency and scalability offered by the product, and significant developments in single-use technology are some of the major market drivers.

Key Market Trends: Growing product adoption in contract manufacturing organizations (CMOs), increasing utilization in cell and gene therapy productions, and significant advancements in bioreactor design are some single-use bioreactors key market trends.

Geographical Trends: North America dominates the market on account of the increasing usage of biopharmaceuticals, rising investment in bioprocessing technologies, and growing benefits of single-use systems more than conventional-steel bioreactors.

Competitive Landscape: ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc., are among some of the key players in the single-use bioreactors industry.

Challenges and Opportunities: Some of the challenges of the industry include high initial product costs and increasing concerns about plastic waste. Whereas, opportunities of the market include the significant technological developments in single-bioreactor designs and the rising demand for personalized medicine and small-batch production.

Single-Use Bioreactors Market Trends:

Rising Adoption of Biopharmaceuticals

The biopharmaceutical industry is rapidly growing on account of the increasing demand for new and effective treatments for numerous diseases, including chronic diseases, such as diabetes, cancer, and autoimmune disorders. According to the IMARC GROUP, the global biopharmaceuticals market has reached US$ 300.5 Billion in 2023, and is expected to reach US$ 643.9 Billion by 2032, exhibiting a CAGR of 8.6% during 2024-2032. Biopharmaceuticals which possess vaccines, monoclonal antibodies, and recombinant proteins, are produced using living cells, which need highly specialized production environments. Single-use bioreactors (SUBs) are highly adopted on account of their cost-efficiency, flexibility, and reduced risk of cross-contamination. They allow quicker product development and production times, thus enabling biopharmaceutical companies to rapidly cater to these demands and develop new therapies for patients.

Rising Investment in Bioprocessing Technologies

The rising investment in bioprocessing technologies is increasing as they seek to improve their production capabilities and enhance operational efficiencies. As per a report published by the IMARC GROUP, the global bioprocess technology market has reached US$ 29.2 Billion in 2023, and is expected to reach US$ 53.3 Billion by 2032, exhibiting a CAGR of 6.93% during 2024-2032. Single-use bioreactors are able to organize the bioprocessing workflow by offering a wide variety of benefits such as reduced capital expenditure, minimized cleaning and validation requirements, and better flexibility in scaling up or down production volumes. Key players are extensively investing in single-use technologies to maximize their production processes, minimize downtime, and achieve cost-efficiency.

Favorable Regulatory Support and Favorable Government Policies

Regulatory agencies and government bodies play a major role in evolving the landscape of biopharmaceutical manufacturing by enduring guidelines and frameworks that guarantee product safety, efficacy, and quality. In recent years, there has been a growing recognition of the benefits of single-use bioreactors (SUBs) within the regulatory community. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have been supportive of single-use technologies due to their ability to reduce contamination risks and improve process efficiencies. This regulatory support has provided a conducive environment for the adoption of SUBs, encouraging biopharmaceutical companies to invest in these systems.

Single-Use Bioreactors Industry Segmentation:

Breakup by Product Type:

  • Single-use Bioreactor Systems
  • Media Bags
  • Filtration Assemblies
  • Others

Single-use bioreactor systems accounts for the majority of the market share

The single-use bioreactors market report has provided a detailed breakup and analysis of the market based on the product type. This includes single-use bioreactor systems, media bags, filtration assemblies, and others. According to the report, single-use bioreactor systems represented the largest segment.

Single-use bioreactor systems dominate the market on account of the numerous benefits offered by them. These are meant for single time usage, which eliminates the need of the vigorous cleaning and sterilization procedure that stainless-steel bioreactors need. This in turn minimizes the downtime between production runs, improves operational efficiency, and reduces the risk of cross-contamination, which is vital in biopharmaceutical production.

Breakup by Type:

  • Stirred-tank Bioreactors
  • Wave-induced Bioreactors
  • Bubble-column Bioreactors
  • Others

Stirred tank bioreactors holds the largest share in the industry

Stirred tank bioreactors hold maximum number of single-use bioreactors market share on account of their efficiency, scalability, and versatility in a wide variety of bioprocessing applications. These bioreactors are built to offer optimized mixing and aeration conditions, which are vital for maintaining uniform cell culture environments and achieving high cell densities and product results. This type of single-use bioreactors is appropriate for both microbial and mammalian cell cultures, thereby making it a preferred choice for creating a wide variety of biopharmaceutical products, such as vaccines, monoclonal antibodies, and recombinant proteins.

Breakup by Cell Type:

  • Mammalian Cell
  • Bacteria
  • Yeast
  • Others

Mammalian cell represents the leading market segment

Mammalian cells hold the largest market share due to several critical factors. Initially, mammalian cells are critical for producing complex biopharmaceuticals such as monoclonal antibodies, recombinant proteins, and vaccines. These therapeutic agents need mammalian cells for their post-translational modifications, which are crucial for their functional and structural integrity. Unlike microbial or yeast cells, mammalian cells can perform glycosylation and other modifications that are vital for the efficacy and safety of biopharmaceutical products. Mammalian cells possess the ability to produce human-like glycosylation patterns which further makes them irreplaceable for the development of biologics that need to mimic natural human proteins closely.

Breakup by Molecule Type:

  • Vaccines
  • Monoclonal Antibodies
  • Stem Cells
  • Recombinant Proteins
  • Others

Vaccines exhibits a clear dominance in the market

Vaccines represent the largest segment due to several compelling factors, such as the rising global demand for vaccines, driven by the continuous upsurge of infectious diseases and the need for rapid and effective immunization strategies. The COVID-19 pandemic is a notable instance that has underlined the importance of vaccines, promoting unprecedented investments in vaccine research, development, and production. Single-use bioreactors have become indispensable in this context because of their flexibility, scalability, and ability to support quick production cycles, which are critical for meeting urgent vaccine demands.

Breakup by End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations
  • Academic and Research Institutes
  • Others

Pharmaceutical and biopharmaceutical companies are the primary end users of single-use bioreactors. These organizations leverage single-use systems for the production of a wide range of therapeutics, including monoclonal antibodies, recombinant proteins, and, notably, vaccines.

Contract Research Organizations (CROs) are significant users of single-use bioreactors, offering outsourced research services to pharmaceutical and biopharmaceutical companies. CROs utilize these systems to conduct various stages of drug development, including preclinical and clinical research.

Academic and research institutes play a crucial role in the innovation and development of new bioprocessing technologies. These institutions use single-use bioreactors for experimental and educational purposes, focusing on the research and development of new drugs, vaccines, and therapeutic proteins.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest single-use bioreactors market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is the largest segment in the single-use bioreactors market by region due to several key factors. The region is home to a robust biopharmaceutical industry with significant investment in research and development. The presence of major pharmaceutical and biotechnology companies, coupled with a strong focus on innovation and advanced manufacturing technologies, drives the demand for single-use bioreactors. Additionally, North America benefits from well-established regulatory frameworks and government support for biopharmaceutical production, particularly in response to public health challenges such as the COVID-19 pandemic.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the single use bioreactors industry include ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players in the single-use bioreactors industry have undertaken several strategic efforts to drive market growth and innovation. Companies such as Thermo Fisher Scientific, Sartorius Stedim Biotech, and GE Healthcare are at the forefront of these initiatives. One major area of focus has been the continuous enhancement of product portfolios through research and development. These companies invest heavily in developing new and improved bioreactor designs that offer greater efficiency, scalability, and ease of use. Innovations such as automated control systems, improved sensors, and better materials for bioreactor components are some of the advancements being pursued.

Key Questions Answered in This Report

  • 1.What was the size of the global single-use bioreactors market in 2024?
  • 2.What is the expected growth rate of the global single-use bioreactors market during 2025-2033?
  • 3.What are the key factors driving the global single-use bioreactors market?
  • 4.What has been the impact of COVID-19 on the global single-use bioreactors market?
  • 5.What is the breakup of the global single-use bioreactors market based on the product type?
  • 6.What is the breakup of the global single-use bioreactors market based on the type?
  • 7.What is the breakup of the global single-use bioreactors market based on the cell type?
  • 8.What is the breakup of the global single-use bioreactors market based on the molecule type?
  • 9.What are the key regions in the global single-use bioreactors market?
  • 10.Who are the key players/companies in the global single-use bioreactors market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Single-use Bioreactor Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Single-use Bioreactor Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Media Bags
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Filtration Assemblies
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Stirred-tank Bioreactors
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Wave-induced Bioreactors
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Bubble-column Bioreactors
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Cell Type

  • 8.1 Mammalian Cells
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Bacteria
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Yeast
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Molecule Type

  • 9.1 Vaccines
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Monoclonal Antibodies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Stem Cells
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Recombinant Proteins
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical and Biopharmaceutical Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Contract Research Organizations
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Academic and Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 ABEC Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Cellexus
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Celltainer Biotech B.V.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 CESCO Bioengineering Co. Ltd.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Distek Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Eppendorf SE
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 SWOT Analysis
    • 16.3.7 General Electric Company
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Getinge AB
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Merck KGaA
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Pall Corporation (Danaher Corporation)
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 SWOT Analysis
    • 16.3.11 PBS Biotech Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Sartorius AG
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Single-use Bioreactor Market: Major Drivers and Challenges
  • Figure 2: Global: Single-use Bioreactor Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Single-use Bioreactor Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Single-use Bioreactor Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Single-use Bioreactor Market: Breakup by Type (in %), 2024
  • Figure 6: Global: Single-use Bioreactor Market: Breakup by Cell Type (in %), 2024
  • Figure 7: Global: Single-use Bioreactor Market: Breakup by Molecule Type (in %), 2024
  • Figure 8: Global: Single-use Bioreactor Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Single-use Bioreactor Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Single-use Bioreactor (Single-use Bioreactor Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Single-use Bioreactor (Single-use Bioreactor Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Single-use Bioreactor (Media Bags) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Single-use Bioreactor (Media Bags) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Single-use Bioreactor (Filtration Assemblies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Single-use Bioreactor (Filtration Assemblies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Single-use Bioreactor (Other Product Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Single-use Bioreactor (Other Product Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Single-use Bioreactor (Stirred-tank Bioreactors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Single-use Bioreactor (Stirred-tank Bioreactors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Single-use Bioreactor (Wave-induced Bioreactors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Single-use Bioreactor (Wave-induced Bioreactors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Single-use Bioreactor (Bubble-column Bioreactors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Single-use Bioreactor (Bubble-column Bioreactors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Single-use Bioreactor (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Single-use Bioreactor (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Single-use Bioreactor (Mammalian Cells) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Single-use Bioreactor (Mammalian Cells) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Single-use Bioreactor (Bacteria) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Single-use Bioreactor (Bacteria) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Single-use Bioreactor (Yeast) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Single-use Bioreactor (Yeast) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Single-use Bioreactor (Other Cell Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Single-use Bioreactor (Other Cell Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Single-use Bioreactor (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Single-use Bioreactor (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Single-use Bioreactor (Monoclonal Antibodies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Single-use Bioreactor (Monoclonal Antibodies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Single-use Bioreactor (Stem Cells) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Single-use Bioreactor (Stem Cells) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Single-use Bioreactor (Recombinant Proteins) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Single-use Bioreactor (Recombinant Proteins) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: Single-use Bioreactor (Other Molecule Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: Single-use Bioreactor (Other Molecule Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Global: Single-use Bioreactor (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Global: Single-use Bioreactor (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Global: Single-use Bioreactor (Contract Research Organizations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Global: Single-use Bioreactor (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Global: Single-use Bioreactor (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Global: Single-use Bioreactor (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Global: Single-use Bioreactor (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Global: Single-use Bioreactor (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: North America: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: North America: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United States: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United States: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Canada: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Canada: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Asia-Pacific: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Asia-Pacific: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: China: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: China: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Japan: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Japan: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: India: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: India: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: South Korea: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: South Korea: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Australia: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Australia: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Indonesia: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Indonesia: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Europe: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Europe: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Germany: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Germany: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: France: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: France: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: United Kingdom: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: United Kingdom: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Italy: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Italy: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Spain: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Spain: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Russia: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Russia: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Others: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Others: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Latin America: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 91: Latin America: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Brazil: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 93: Brazil: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 94: Mexico: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 95: Mexico: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 96: Others: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 97: Others: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033

Figure 98 Middle East and Africa: Single-use Bioreactor Market: Sales Value (in Million USD), 2019 & 2024

  • Figure 99: Middle East and Africa: Single-use Bioreactor Market: Breakup by Country (in %), 2024
  • Figure 100: Middle East and Africa: Single-use Bioreactor Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 101: Global: Single-use Bioreactor Industry: SWOT Analysis
  • Figure 102: Global: Single-use Bioreactor Industry: Value Chain Analysis
  • Figure 103: Global: Single-use Bioreactor Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Single-use Bioreactor Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Single-use Bioreactor Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Single-use Bioreactor Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 4: Global: Single-use Bioreactor Market Forecast: Breakup by Cell Type (in Million USD), 2025-2033
  • Table 5: Global: Single-use Bioreactor Market Forecast: Breakup by Molecule Type (in Million USD), 2025-2033
  • Table 6: Global: Single-use Bioreactor Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Single-use Bioreactor Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Single-use Bioreactor Market: Competitive Structure
  • Table 9: Global: Single-use Bioreactor Market: Key Players